The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.EBI
University of Oxford
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable EBI
Sanders Tri-Institutional Therapeutics
Design, synthesis of novel benzimidazole derivatives as ENL inhibitors suppressing leukemia cells viability via downregulating the expression of MYC.EBI
Nanchang University
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.EBI
Pfizer
Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.EBI
China Pharmaceutical University
Spiroarborin, an EBI
Yunnan University
Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain.EBI
Texas A&M University
Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1.EBI
Goethe-University Frankfurt
Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL).EBI
Goethe-University Frankfurt
Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL.EBI
China Pharmaceutical University